BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

  May 14, 2025

   · 

  12 min read
• Press Releases

  NeuroPace Reports First Quarter 2025 Financial Results

  May 14, 2025

   · 

  10 min read
• Press Releases

  Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update

  May 14, 2025

   · 

  17 min read
• Press Releases

  Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update

  May 14, 2025

   · 

  8 min read
• Press Releases

  Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

  May 14, 2025

   · 

  20 min read
• Press Releases

  Invenra Highlights Exelixis’ Initiation of Phase 1 Clinical Study Evaluating XB628, a First-in-Class Bispecific Antibody in Participants with Recurrent Advanced or Metastatic Solid Tumors

  May 14, 2025

   · 

  1 min read
• Press Releases

  Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

  May 14, 2025

   · 

  8 min read
• Press Releases

  Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat

  May 14, 2025

   · 

  3 min read
• Press Releases

  GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

  May 14, 2025

   · 

  8 min read
• Press Releases

  Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments

  May 14, 2025

   · 

  3 min read